Skip to main content
TipRanks
Go Ultimate75% OFF

Alaunos Therapeutics (TCRT) Income Statement

701 Followers

Alaunos Therapeutics Income Statement

Last quarter (Q2 2026), Alaunos Therapeutics's total revenue was $0.00. In Q2, Alaunos Therapeutics's net income was $-952.00K. See Alaunos Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 5.00K$ 10.00K$ 5.00K$ 2.92M$ 398.00K
$ -1.36M$ -352.00K$ -4.80M$ -19.60M$ -46.88M
$ 2.87M$ 4.46M$ 29.47M$ 15.51M$ 30.67M
Depreciation and Amortization$ 7.00K$ 2.00K$ 2.31M$ 2.76M$ 2.60M
$ -4.17M$ -4.68M$ -30.90M$ -31.82M$ -74.97M
$ -4.22M$ -4.81M$ -34.27M$ -35.10M$ -77.55M
$ 49.00K$ 133.00K$ -873.00K$ -2.63M$ -1.20M
$ -4.18M$ -4.68M$ -35.14M$ -37.73M$ -78.75M
$ -4.18M$ -4.68M$ -35.14M$ -37.73M$ -78.75M
Per Share Metrics
Basic EPS$ -2.20$ -2.92$ -21.97$ -25.97$ -53.80
Diluted EPS$ -2.20$ -2.92$ -21.97$ -25.97$ -53.80
Weighted Average Shares Outstanding1.95M1.60M1.60M1.45M1.43M
Weighted Average Shares Outstanding (Diluted)1.95M1.60M1.60M1.45M1.43M

Currency in USD

Alaunos Therapeutics Earnings and Revenue History

-160M-80M080M-750000 %-500000 %-250000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin